Dozens Savings plc
Admission to AQSE Growth Market
The Directors of Dozens Savings plc are pleased to announce that 994 5% Secured Bonds January 2021 of £100 principal amount each (the "Bonds") have been admitted today to trading on the AQSE Growth Market. The Bonds, which have an aggregate principal amount of £99,400, mature on 1 February 2022 and represent the thirteenth series of Dozens Savings' 5.00% fixed-rate, secured £7 million bond programme. The Bonds will trade under the ISIN 'GB00BMDGGB14' and the ticker symbol 'DS13'. When combined with its previous series, Dozens Savings plc has issued bonds in the aggregate principal amount of £2,866,900.
Dozens Savings plc offers a fixed income financial investment product, namely, 5% fixed-rate secured bonds, to customers of its corporate parent, Project Imagine Ltd. Project Imagine aims to create an improved, second-generation financial management alternative from scratch-disrupting banking and money problems via a solution that enables users to pursue a simple and equitable financial future.
Further details regarding the Bonds are contained in Dozens Savings' Base Admission Document dated 14 February 2019 and its Pricing Supplement dated 25 January 2021, both of which can be found via the issuer's website, https://www.dozens.com/aquisannouncements/regulatory-announcements/.
The directors of Dozens Savings plc accept responsibility for this announcement.
For further information, please contact:
Dozens Savings plc
Tel: 0808 164 1020
Alfred Henry Corporate Finance Limited
AQSE Corporate Advisor to Dozens Savings plc
Attn: Jon Isaacs
Tel: +44 (0) 203 772 0021
This information is provided by RNS, the news service of the
. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom
. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact firstname.lastname@example.org
or visit www.rns.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the